Relationship between serum magnesium values, lipids and anthropometric risk factors

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 413-419

  Randell, Edward W ^a,b   Mathews, Maria ^a   Gadag, Veeresh ^a   Zhang, Hongwei ^a   Sun, Guang ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Health Care Corporation of St John's   (Canada)

Author keywords

Cholesterol; Diabetes; Hyperlipidemia; Insulin resistance; Magnesium; Metabolic syndrome; Obesity

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION;

ADIPOSE TISSUE; ADULT; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPOPROTEINS; MAGNESIUM; MALE; MIDDLE AGED; NEWFOUNDLAND AND LABRADOR; OBESITY; RISK FACTORS;

EID: 38049023019     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.11.024     Document Type: Article

References (32)

1. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz textbook of clinical chemistry. 2nd ed. (1994), Saunders Company, USA 1324-1327
2. Bonow R.O., and Eckel R.H. Diet, obesity and cardiovascular risk. N Engl J Med 348 (2003) 2057-2058
3. Kao W.H., Folsom A.R., Nieto F.J., et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The Atherosclerosis risk in communities study. Arch Int Med 159 (1999) 2151-2159
4. Liao F., Folsom A.R., and Brancati F.L. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 136 (1998) 480-490
5. He K., Liu K., Daviglus M.L., et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113 (2006) 1675-1682
6. McCarty M.F. Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist. Med Hypotheses 64 (2005) 619-627
7. Corica F., Corsonello A., Ientile R., et al. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 25 (2006) 210-215
8. Guerrero-Romero F., and Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 39 (2002) 209-213
9. Guerrero-Romero F., and Rodriguez-Moran M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complications 14 (2000) 272-276
10. Nerbrand C., Agreus L., Lenner R.A., Nyberg P., and Svardsudd K. The influence of calcium and magnesium in drinking water and diet on cardiovascular risk factors in individuals living in hard and soft water areas with differences in cardiovascular mortality. BMC Public Health 3 (2003) 21-29
11. Robles N.R., Escola J.M., Albarran L., and Espada R. Correlation of serum magnesium and serum lipid levels in hemodialysis patients. Nephron 78 (1998) 118-119
12. Sun G., French C.R., Martin G.R., et al. Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr 81 (2005) 74-78
13. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
14. Levy J.C., Matthews D.R., and Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998) 2191-2192
15. Gallagher D., Heymsfield S.B., Heo M., et al. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 72 (2000) 694-701
16. Walti M., Zimmermann M.B., Spinas G.A., and Hurrell R.F. Low plasma magnesium in type 2 diabetes. Swiss Med Wkly 133 (2003) 289-292
17. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys; 2006 [Epub ahead of print].
18. Atabek M.E., Kurtoglu S., Pirgon O., and Baykara M. Serum magnesium concentrations in type 1 diabetic patients: relation to early atherosclerosis. Diabetes Res Clin Pract 72 (2006) 42-47
19. Guerrero-Romero F., and Rodriguez-Moran M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev 22 (2006) 471-476
20. Petersen B., Schroll M., Christiansen C., and Transbol I. Serum and erythrocyte magnesium in normal elderly Danish people. Relationship to blood pressure and serum lipids. Acta Med Scand 201 (1977) 31-34
21. Haenni A., Ohrvall M., and Lithell H. Atherogenic lipid fractions are related to ionized magnesium status. Am J Clin Nutr 67 (1998) 202-207
22. Yokota K., Kato M., Lister F., et al. Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 23 (2004) 506S-509S
23. Djurhuus M.S., Henriksen J.E., Klitgaard N.A., et al. Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care 22 (1999) 546-554
24. Kisters K., Spieker C., Tepel M., and Zidek W. New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res 6 (1993) 355-360
25. Marken P.A., Weart C.W., Carson D.S., Gums J.G., and Lopes-Virella M.F. Effects of magnesium oxide on the lipid profile of healthy volunteers. Atherosclerosis 77 (1989) 37-42
26. Rasmussen H.S., Aurup P., Goldstein K., et al. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study. Arch Intern Med 149 (1989) 1050-1053
27. Bastida S., Vaquero M.P., Veldhuizen M., and Sanchez-Muniz F.J. Selected trace elements and minerals in cord blood: association with lipids and lipoproteins at birth. Acta Paediatr 89 (2000) 1201-1206
28. Nozue T., Kobayashi A., Uemasu F., et al. Magnesium status, serum HDL cholesterol, and apolipoprotein A-1 levels. J Pediatr Gastroenterol Nutr 20 (1995) 316-318
29. Rosanoff A., and Seelig M.S. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr 23 (2004) 501S-505S
30. + cations. Lipids 27 (1992) 551-559
31. 2+ with phosphatidylserines: effect of hydrocarbon chain unsaturation. Biochim Biophys Acta 982 (1989) 228-236
32. Orchard T.J. Magnesium and type 2 diabetes mellitus. Arch Intern Med 159 (1999) 2119-2120